Orchestra BioMed Holdings, Inc. Other General Expense
Orchestra BioMed Holdings, Inc. (OBIO) reported Other General Expense of $75.00 thousand for the 7-month period ending 2020-12-31, per its 10-K/A filed 2022-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherGeneralExpense · last filed 2022-03-31
- 2020-12-31: Other General Expense 7 month $75.00K.
- 2020-09-30: Other General Expense 4 month $70.00K.
- 2020-06-30: Other General Expense 1 month $15.00K.
| Period end | Other General Expense 1 month | Other General Expense 4 month | Other General Expense 7 month |
|---|---|---|---|
| 2020-12-31 | $75.00K 10-K/A · filed 2022-03-31 | ||
| 2020-09-30 | $70.00K 10-Q/A · filed 2022-03-31 | ||
| 2020-06-30 | $15.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |